1. Home
  2. BHRB vs COLL Comparison

BHRB vs COLL Comparison

Compare BHRB & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

SELL

Current Price

$70.15

Market Cap

1.4B

Sector

Finance

ML Signal

SELL

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

SELL

Current Price

$22.23

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BHRB
COLL
Founded
1852
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
BHRB
COLL
Price
$70.15
$22.23
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
★ $80.00
$49.00
AVG Volume (30 Days)
119.7K
★ 770.8K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 3.15%
N/A
EPS Growth
★ 173.76
N/A
EPS
★ 2.16
N/A
Revenue
N/A
★ $780,567,000.00
Revenue This Year
$26.22
$6.84
Revenue Next Year
$12.96
$1.25
P/E Ratio
$32.39
★ N/A
Revenue Growth
N/A
★ 23.62
52 Week Low
$57.42
$21.43
52 Week High
$75.09
$50.79

Technical Indicators

Market Signals
Indicator
BHRB
COLL
Relative Strength Index (RSI) 52.45 35.65
Support Level $68.10 $21.54
Resistance Level $70.82 $23.69
Average True Range (ATR) 1.18 0.72
MACD 0.12 0.25
Stochastic Oscillator 83.57 34.07

Price Performance

Historical Comparison
BHRB
COLL

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: